SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
Australian scientists who discovered how to "turn off" genes that make cancer cells grow are celebrating the next phase of development – with Pfizer's...
Highlights: Up to 235% increase in real-world adherence compared to published norms (20–40%), across ~850 chronic obstructive pulmonary disease (COPD)...
TOKYO, Sept. 15, 2025 /PRNewswire/ -- The highly popular social entertainment app WePlay announced today that, to express gratitude for users' longstanding support, it has...
HONG KONG, Sept. 15, 2025 /PRNewswire/ -- On 12 September, Home Control (1747.HK) announced a strategic expansion into the healthcare sector with plans to...
